PlasmACT

PlasmACT is a Marie Skłodowska-Curie Doctoral Network coordinated by the Leibniz Institute for Plasma Research and Technology in Greifswald, Germany, in collaboration with four other academic partners: University Medical Center Rostock, Germany, Eindhoven University of Technology, The Netherlands, Centre national de la recherche scientifique, France and University of Antwerp, Belgium. In addition to our partners, our project also includes eight associated industry partners and two NGOs. Our mission is to explore the potential of medical gas plasma technology in treating Actinic Keratosis, a common skin condition that can lead to skin cancer. Through PlasmACT, we aim not only to make scientific advancements but also to cultivate a new generation of scientists capable of addressing complex healthcare challenges from both academic and commercial perspectives. By fostering a dynamic, international environment that encourages collaboration and innovation, we strive to accelerate progress in the field of medical gas plasma technology and improve outcomes for patients with Actinic Keratosis and beyond. Join us on this exciting journey as we unlock the potential of plasma technology to revolutionize healthcare and combat skin cancer. This project has received funding from the European Union's Horizon Europe research and innovation programme under grant agreement no.101118430.